Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02954536
Brief Title: Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer

First Submitted : November 2, 2016
First Submitted that Met QC Criteria : November 2, 2016
First Posted : November 3, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 5, 2019
Last Update Posted : June 6, 2019